레이저를 이용한 가축 접합체의 세포질 미세 주입을

Executive Industry Relevance

Laser-assisted cytoplasmic microinjection enables precise delivery of genome editing tools into livestock zygotes, supporting target validation in large animal models. This technique addresses a key bottleneck in transgenesis by improving injection efficiency and reducing embryo lysis, thereby enhancing predictive confidence in preclinical target de-risking. It provides a scalable method for generating genetically modified livestock to study gene function and therapeutic mechanisms.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables functional interrogation of therapeutic targets through delivery of CRISPR-Cas9 or siRNA into zygotes for phenotypic assessment.
• Operational Value: Achieves 100% injection efficiency in bovine and ovine zygotes with minimal lysis, ensuring reliable target modulation.
• Predictive Value: Supports mechanistic de-risking by generating germline modifications present in all cells of the adult organism.

Screening & Assay Development

• Scientific Value: Delivers mRNAs, blocking antibodies, or genome editing tools to study gene function in preimplantation embryos with high spatial accuracy.
• Operational Value: Uses laser-assisted zona pellucida perforation and blunt-end micropipette to overcome visualization challenges in dark, elastic livestock cytoplasm.
• Assay Readiness: Produces homogeneous cytoplasmic distribution of injected solutions, validated by fluorescent tracking (e.g., dextran red), enabling quantitative readouts.

Translational & Preclinical Research

• Translational Continuity: Generates transgenic livestock models with genome edits present in every cell, improving relevance to human disease pathways.
• Preclinical Model: Supports creation of large animal models for target validation where rodent systems lack physiological relevance.
• Risk-Adjusted Advancement: Shows no statistically significant differences in blastocyst development rates between injected and control embryos, indicating minimal developmental toxicity.

Pipeline & Workflow Integration

This method integrates into the discovery continuum from target hypothesis testing through lead identification to preclinical validation in livestock models.

• Discovery Biology: Facilitates hypothesis testing by enabling delivery of genome editing tools to assess target function in early embryos.
• Screening: Delivers siRNA, mRNAs, or antibodies to modulate gene expression and evaluate phenotypic outcomes in a reproducible system.
• Analytics: Enables quantitative assessment via fluorescent tracers to confirm injection accuracy and cytoplasmic distribution.
• Translational Research: Produces livestock models with full-body gene modifications, enhancing preclinical relevance for target validation.
• Enterprise Reuse: Establishes a standardized, reusable platform for transgenesis across cattle, sheep, and pig zygotes.

Operational & Enterprise Impact

• Scientific Value: Predictive confidence in target validation through efficient, homogeneous delivery of modulating agents into zygotes.
• Operational Value: High reproducibility with 100% success rate, minimal embryo lysis, and normal blastocyst formation.
• Strategic Value: Reduces biological risk in target selection by enabling reliable large animal model generation.
• Portfolio Impact: Supports risk-adjusted prioritization of targets via functional validation in physiologically relevant species.

Implementation Considerations

• Expertise in micropipette preparation using a borosilicate glass capillary, puller, and microforge for tip shaping and fire-polishing.
• Requirement for laser system to perforate zona pellucida and micromanipulators for precise needle positioning.
• Need for standardized culture media (e.g., SOF-HEPES with FBS) and mineral oil overlay to maintain embryo viability during injection.
• Adaptation considerations for different livestock species based on zona pellucida thickness and cytoplasmic properties.
• Practical limitation: Requires skilled operators to coordinate laser targeting, needle advancement, and cytoplasmic aspiration without embryo damage.

Biopharma FAQs